-

About the talk

Emerging economies such as China and India have become “hotspots” of multinational R&D investments. As some observers have argued, some unique products/services are first developed in and for emerging markets, then subsequently introduced to advanced markets. This is named “reverse innovation” and proclaimed to bring great challenges for existing industrial dominators (Immelt, Govindarajan & Trimble, 2009). If true, what would be its impact on multinational global R&D strategies and organizations? What kind of capabilities and mechanism should be developed to respond this change?

Based on case studies in China, Dr. Liang will discuss three new types of multinationals’ R&D units abroad. All of them are host-country-based instead of home-country-based, which indicates the latest change of multinational global R&D distribution. Furthermore, the talk will also explore the global R&D strategy and innovation pattern of Chinese home-grown companies such as Huawei and ZTE, and the relationship between multinationals’ R&D relocation in China, as well as their implications on global innovation landscape.

About the speaker

Dr. LIANG Zheng is currently working at the MIT Industrial Performance Center (IPC) as the Fulbright Visiting Research Scholar. Presently he is carrying out research projects on multinationals’ global R&D network expansion and integration, as well as the internationalization of new industrial leaders from emerging economies. He serves as the associate professor of the School of Public Policy and Management, Tsinghua University, as well as the research fellow and assistant director of China Institute for Science & Technology Policy at Tsinghua University (CISTP), which is jointly established by Ministry of Science and Technology of China and Tsinghua University, mainly focusing on the studies of S&T policy and the national strategy of S&T development. Before joining Tsinghua University, Dr. Liang served as the associate professor of the International Business School in Nankai University. He got his doctor’s degree of economics at Nankai University (2003) and accomplished the senior executive training program on leadership at Kennedy School of Government, Harvard University (2010). The main areas of his research focus on globalization of R&D, IPRs and standardization and the National Innovation System. Dr. Liang has also participated in some of China’s key research projects such as the Strategic Research for National Medium and Long Term Science and Technology Development Program.

E103, Faculty Building East, Knight Management Center, Stanford Graduate School of Business, 655 Knight Way, Stanford, CA 94305-7298

LIANG, Zheng Associate Professor, School of Public Policy and Management Speaker Tsinghua University
0
FSI Senior Fellow Emeritus and Director-Emeritus, Shorenstein APARC
H_Rowen_headshot.jpg

Henry S. Rowen was a senior fellow at the Hoover Institution, a professor of public policy and management emeritus at Stanford University's Graduate School of Business, and a senior fellow emeritus of the Walter H. Shorenstein Asia-Pacific Research Center (Shorenstein APARC). Rowen was an expert on international security, economic development, and high tech industries in the United States and Asia. His most current research focused on the rise of Asia in high technologies.

In 2004 and 2005, Rowen served on the Presidential Commission on the Intelligence of the United States Regarding Weapons of Mass Destruction. From 2001 to 2004, he served on the Secretary of Defense Policy Advisory Board. Rowen was assistant secretary of defense for international security affairs in the U.S. Department of Defense from 1989 to 1991. He was also chairman of the National Intelligence Council from 1981 to 1983. Rowen served as president of the RAND Corporation from 1967 to 1972, and was assistant director of the U.S. Bureau of the Budget from 1965 to 1966.

Rowen most recently co-edited Greater China's Quest for Innovation (Shorenstein APARC, 2008). He also co-edited Making IT: The Rise of Asia in High Tech (Stanford University Press, 2006) and The Silicon Valley Edge: A Habitat for Innovation and Entrepreneurship (2000). Rowen's other books include Prospects for Peace in South Asia (edited with Rafiq Dossani) and Behind East Asian Growth: The Political and Social Foundations of Prosperity (1998). Among his articles are "The Short March: China's Road to Democracy," in National Interest (1996); "Inchon in the Desert: My Rejected Plan," in National Interest (1995); and "The Tide underneath the 'Third Wave,'" in Journal of Democracy (1995).

Born in Boston in 1925, Rowen earned a bachelors degree in industrial management from the Massachusetts Institute of Technology in 1949 and a masters in economics from Oxford University in 1955.

Faculty Co-director Emeritus, SPRIE
Senior Fellow, Hoover Institution
Henry S. Rowen Co-Director, SPRIE Host Stanford Graduate School of Business
Seminars
Authors
News Type
News
Date
Paragraphs

A revelatory story emerged in China this spring: Bo Xilai, Chongqing’s powerful Communist Party head, was stripped of both his post and party membership and accused of shocking abuses of power, including covering up his wife’s alleged involvement in the death of a shadowy British businessman.

On May 2, the Shorenstein Asia-Pacific Research Center held a special seminar to make sense of what this unusual high-level scandal could mean for the future of China’s current political system, erupting just months ahead of a once-in-a-generation leadership transition.

Minxin Pei, director of the Keck Center for International and Strategic Studies at Claremont McKenna College, said the scandal is a severe test for the Chinese Communist Party (CCP), which balances on a knife’s edge as it prepares to replace the majority of its Politburo members—the highest CCP echelon. The Bo affair has exposed the existence of serious corruption at a very high level of government, calling into question the party’s image and credibility.

“This is the biggest threat to party unity since 1989,” he said.

More potentially damaging still, however, is the negative light it has cast on China’s overall political system. The scandal has revealed weaknesses and loopholes in the power structure, and the government’s poor crisis management skills.

“The Bo Xilai affair is the beginning of the end of the Tiananmen era,” Pei said. “Twenty years from now, historians will make this point.”

Xueguang Zhou, a professor of sociology and Freeman Spogli Institute senior fellow, agreed with Pei’s analysis that Bo’s fall from power has tarnished the party’s image and deeply disrupted the cohesiveness of its upper leadership.He spoke also of the outpouring of criticism on social media sites for the government’s inability to reign in corruption—so much so that censors have not been able to keep up.

“These voices have been so fierce in criticizing the top leadership that it has huge implications for the emergence of China’s civil society,” Zhou said. 

He expressed his concern for the future of local politics after the smoke from the Bo affair has cleared. Although it is widely acknowledged in China that shady political dealings go hand-in-hand with local-level politics, positive innovations in governance also frequently occur at the city and county level.

“I hope that local governments will still have the power to experiment,” he said.

After all is said and done, China’s top leadership is at a major turning point. Only time will tell the full impact of the fall of Bo Xilai, both during this year’s power transition and the evolution of China’s government structure in the coming decades.

Hero Image
ChongqingBridge NEWSFEED
A rain-spattered window and misty bridge in Chongqing, October 2011, one month before the death of British businessman Neil Heywood.
Flickr/International Hydropower Association; http://bit.ly/J8JSoh
All News button
1

Walter H. Shorenstein
Asia-Pacific Research Center
616 Serra St C332
Stanford University
Stanford, CA 94305-6055

(650) 724-5710 (650) 723-6530
0
Visiting Associate Professor
MaiQiang_WEB.jpg PhD

Mai Qiang joins the Walter H. Shorenstein Asia-Pacific Research Center (Shorenstein APARC) during the 2012–13 academic year from the Harbin Institute of Technology’s Management School where he serves as an associate professor.

His research interests encompass the process of reform in Chinese state-owned enterprises; decision making in hierarchical organization structures; evolution mechanisms underlying risk decisions; and operations research. During his time at Shorenstein APARC, Mai will participate in an interdisciplinary study evaluating the degree of internationalization that occurs in transnational enterprises in China and the United States.

Mai holds a PhD in management science and engineering from Harbin Institute of Technology.

-

In spring 2009, China’s leadership announced ambitious national health reforms. Have the five stated goals of the first three years of reform been met? What policies will China pursue in the next phase? As a prominent advisor to China's State Council Health Reform Office, Liu will discuss progress and prospects for reforms—especially the role of the private sector within the health system—within the context of China’s 2012 leadership transition.

Gordon Liu is a professor of economics at Peking University's (PKU) Guanghua School of Management, and director of PKU's China Center for Health Economic Research. Previously, he served as a tenured associate professor at the University of North Carolina at Chapel Hill (2000–2006), and as an assistant professor at the University of Southern California (1994–2000).

Liu's primary research interests include health and development economics, health policy and reform, and pharmaceutical economics. His current research is funded by the State Council Health Reform Office, the National Science Foundation, UNICEF, and the China Medical Board.

Liu currently serves on the State Council Health Reform Advisory Commission, and the Expert Panel for the State Ministry of Human Resource and Social Security. He serves as co-editor for the journal Value in Health, and as editor-in-chief for China Journal of Pharmaceutical Economics. He sits on the editorial boards for the European Health Economic Review, Global Handbook for Health Economics, and Chinese Journal of Health Economics.

He received his PhD in Economics from the City University of New York Graduate School while working as a graduate research fellow at the National Bureau of Economic Research under the supervision of Michael Grossman (1986–1991). He obtained post-doctoral training at Harvard University with William Hsiao (1992–1993). Liu has served as the president for the Chinese Economists Society, and chair for the Asian Consortium for the International Society for Pharmacoeconomics and Outcomes Research.

Philippines Conference Room

Gordon Liu Professor of Economics Speaker Peking University Guanghua School of Management
Seminars
Authors
News Type
Q&As
Date
Paragraphs

China’s demographic landscape is rapidly changing, and the government has responded by launching ambitious social and health service reforms to meet the changing needs of the country’s 1.3 billion people. This week, officials approved a five-year plan to develop a comprehensive nationwide social security network.

Karen Eggleston, the Asia Health Policy Program (AHPP) director and a Stanford Health Policy fellow, discusses the success of China’s health care reforms—including its recently established universal health care system—and the long road still ahead.

Why is the overall health and wellbeing of China’s population important globally?

There are many reasons why the health of China’s citizens matters within a larger global context. On the most basic level, China represents almost 20 percent of humanity. But it is also a major player in the world economy and it depends on having a healthy workforce, especially now that its population is aging more. The government’s ability to meet the needs of its underserved citizens contributes to a more productive and stable China, and works towards closing the huge gaps we see in human wellbeing across the world.

China also potentially offers a model for other developing countries, such as India, that may want to figure out how to make universal health coverage work at a tenth of the income of most of the countries that have put it into place before.

What are some of the biggest changes in China’s health care system since 1949?

One of the most significant changes is that China has achieved very basic universal health insurance coverage in a relatively short period of time.  

Throughout the Mao period (1949–1978) there was a health care system linked to the centrally planned economy, which provided a basic level of coverage via government providers with a lot of regional variation. When economic reform came in 1980, large parts of the system—particularly financing for insurance—collapsed. The majority of China’s citizens were uninsured during the past few decades of very rapid social and economic development.

China’s overall population is changing quite dramatically, which means it has different health care needs, such as treating chronic disease and caring for an increasingly elderly population. The central government is trying to establish a system of accessible primary care—a concept that China’s barefoot doctors helped to pioneer but that fell into disarray—and health services that fit these new needs. 

How does China’s basic health care system work? Are there segments of the population still not receiving adequate coverage and care?

China has had a system where people can select their own doctors. Patients usually want to go to clinics attached to the highest-reputation hospitals, but of course, when you are not insured you almost always by default go to where you can afford the care. “It is difficult to see the doctor, and it is expensive” has been the lament of patients in China, so an explicit goal of the health care reforms has been to address this.

The term “universal coverage” has different definitions. China initially put in place a form of insurance that only covers 20 or 30 percent of medical costs for the previously uninsured population, especially in rural areas. Benefits have expanded, but remain limited. As with the previous system, disparities in coverage still exist across the population. China not only has a huge population with huge economic differences, but within that there is a large migrant worker population. It is a challenge to figure out how to cover these citizens and how to provide them with access to better care. The government is quite aware there are segments of the population not receiving equal coverage, and it continues to strive to resolve the issue.  

What are the greatest innovations in China’s health care system in recent years?

One of the most remarkable things China has achieved is really its new health insurance system. Even if the current coverage is not particularly generous it is nearly universal, and mechanisms are put in place each year to provide more generous coverage. China is also working on strengthening its primary care and population health services, infusing a huge sum of government money into these efforts. It is the only developing country of its per-capita income that has achieved such results so far.

Interestingly, a lot of people assume China achieved its universal coverage by mandate, while in fact the central government did so by subsidizing the cost for local governments and individuals. This reduces the burden, for example, on poorer rural governments and residents, and is one innovative way China is trying to eliminate the disparity in access to care.

Eggleston has recently published a working paper on China’s health care reforms since the Mao era on the AHPP website, as well as an article in the Milken Institute Review.

Gordon Liu, a Chinese government advisor on health care and the executive director of Peking University’s Health Economics and Management Institute, spoke at Stanford on May 29 on the future of China’s health care system.

Hero Image
ShanghaiHealthImperative LOGO
A disabled woman from Henan writes a poetic plea for money explaining the circumstances of her disability, her family's difficulties in paying for treatment, and their subsequent debt, Shanghai, August 2009.
Flickr/Santo Chino; http://bit.ly/IGKsL1
All News button
1
Subscribe to China